IDEAS home Printed from https://ideas.repec.org/d/heleeuk.html

Publications

by members of

University of Leeds → Leeds Institute of Health Sciences → Academic Unit of Health Economics

These are publications listed in RePEc written by members of the above institution who are registered with the RePEc Author Service. Thus this compiles the works all those currently affiliated with this institution, not those affilated at the time of publication. List of registered members. Register yourself. Citation analysis. This page is updated in the first days of each month.
| Working papers | Journal articles |

Working papers

2019

  1. Panos Kasteridis & Dan Liu & Anne Mason & Maria Goddard & Rowena Jacobs & Raphael Wittenberg & Daniel Howdon, 2019, "The impact of primary care incentive schemes on care home placements for people with dementia," Working Papers, Centre for Health Economics, University of York, number 164cherp, May.

2017

  1. Chris Bojke & Adriana Castelli & Katja Grasic & Daniel Howdon & Andrew Street, 2017, "Productivity of the English NHS: 2014/15 Update," Working Papers, Centre for Health Economics, University of York, number 146cherp, Apr.
  2. Daniel Howdon & James Lomas, 2017, "Pricing implications of non-marginal budgetary impacts in health technology assessment: a conceptual model," Working Papers, Centre for Health Economics, University of York, number 148cherp, Nov.

2016

  1. Chris Bojke & Adriana Castelli & Katja Grasic & Daniel Howdon & Andrew Street, 2016, "Productivity of the English NHS: 2013/14 update," Working Papers, Centre for Health Economics, University of York, number 126cherp, Jan.

2015

  1. Daniel Howdon & Nigel Rice, 2015, "Health care expenditures, age, proximity to death and morbidity: implications for an ageing population," Working Papers, Centre for Health Economics, University of York, number 107cherp, Jan.

2013

  1. Howdon, D. & Jones, A., 2013, "A discrete latent factor model for smoking, cancer and mortality," Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York, number 13/14, Jun.

2012

  1. Howdon, D., 2012, "Time and chance happen to them all? Duration modelling versus lifetime incidence of cancer," Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York, number 12/06, Apr.

2008

  1. McCabe, C & Claxton, K & Culyer, AJ, 2008, "The NICE Cost-Effectiveness Threshold: What it is and What that Means," MPRA Paper, University Library of Munich, Germany, number 26466.

2005

  1. Karl Claxton & Simon Eggington & Laura Ginnelly & Susan Griffin & Christopher McCabe & Zoe Philips & Paul Tappenden & Alan Wailoo, 2005, "A Pilot Study of Value of Information Analysis to Support Research Recommendations for the National Institute for Health and Clinical Excellence," Working Papers, Centre for Health Economics, University of York, number 004cherp, Jun.
  2. Yu, Ge, 2005, "Excess sensitivity of consumption using micro data in the UK," MPRA Paper, University Library of Munich, Germany, number 548, revised 2006.

2004

  1. McCabe, C & Brazier, J & Gilks, P & Tsuchiya, A & Roberts, J & O'Hagan, A & Stevens, K, 2004, "Estimating population cardinal health state valuation models from individual ordinal (rank) health state preference data," MPRA Paper, University Library of Munich, Germany, number 29759, May.

2003

  1. McCabe, C & Stevens, K & Roberts, J & Brazier, JE, 2003, "Health state values for the HUI 2 descriptive system: results from a UK survey," MPRA Paper, University Library of Munich, Germany, number 29744, Nov.
  2. Yu, Ge, 2003, "Comparing Expectations and Outcomes: Application to UK Data," MPRA Paper, University Library of Munich, Germany, number 502, revised 2005.

Journal articles

2019

  1. Viola Angelini & Daniel D H Howdon & Jochen O Mierau, 2019, "Childhood Socioeconomic Status and Late-Adulthood Mental Health: Results From the Survey on Health, Ageing and Retirement in Europe," The Journals of Gerontology: Series B, The Gerontological Society of America, volume 74, issue 1, pages 95-104.
  2. Jenni Murray & Nyantara Wickramasekera & Marjolein Elings & Rachel Bragg & Cathy Brennan & Zoe Richardson & Judy Wright & Marina G. Llorente & Janet Cade & Darren Shickle & Sandy Tubeuf & Helen Elsey, 2019, "The impact of care farms on quality of life, depression and anxiety among different population groups: A systematic review," Campbell Systematic Reviews, John Wiley & Sons, volume 15, issue 4, December, DOI: 10.1002/cl2.1061.

2018

  1. Howdon, Daniel & Rice, Nigel, 2018, "Health care expenditures, age, proximity to death and morbidity: Implications for an ageing population," Journal of Health Economics, Elsevier, volume 57, issue C, pages 60-74, DOI: 10.1016/j.jhealeco.2017.11.001.

2017

  1. David M. Meads & John L. O’Dwyer & Claire T. Hulme & Phani Chintakayala & Karen Vinall-Collier & Michael I. Bennett, 2017, "Patient Preferences for Pain Management in Advanced Cancer: Results from a Discrete Choice Experiment," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, volume 10, issue 5, pages 643-651, October, DOI: 10.1007/s40271-017-0236-x.

2016

  1. Joanne O’Connor & Stephen Rice & Alison Smith & Mark Rodgers & Rocio Rodriguez Lopez & Dawn Craig & Nerys Woolacott, 2016, "The Clinical and Cost Effectiveness of Ustekinumab for the Treatment of Psoriatic Arthritis: A Critique of the Evidence," PharmacoEconomics, Springer, volume 34, issue 4, pages 337-348, April, DOI: 10.1007/s40273-015-0350-3.

2015

  1. Howdon, Daniel & Jones, Andrew M., 2015, "A discrete latent factor model for smoking, cancer and mortality," Economics & Human Biology, Elsevier, volume 18, issue C, pages 57-73, DOI: 10.1016/j.ehb.2015.03.004.
  2. Ros Wade & Ana Duarte & Mark Simmonds & Rocio Rodriguez-Lopez & Steven Duffy & Nerys Woolacott & Eldon Spackman, 2015, "The Clinical and Cost Effectiveness of Aflibercept in Combination with Irinotecan and Fluorouracil-Based Therapy (FOLFIRI) for the Treatment of Metastatic Colorectal Cancer Which has Progressed Following Prior Oxaliplatin-Based Chemotherapy: a Critiq," PharmacoEconomics, Springer, volume 33, issue 5, pages 457-466, May, DOI: 10.1007/s40273-015-0257-z.

2013

  1. Yemi Oluboyede & Sandy Tubeuf & Chris McCabe, 2013, "Measuring health outcomes of adolescents: report from a pilot study," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), volume 14, issue 1, pages 11-19, February, DOI: 10.1007/s10198-011-0340-0.
  2. Peter Hall & Christopher McCabe, 2013, "What Evidence Is There for the Reimbursement of Personalised Medicine?," PharmacoEconomics, Springer, volume 31, issue 3, pages 181-183, March, DOI: 10.1007/s40273-013-0025-x.
  3. Christopher McCabe & Richard Edlin & Peter Hall, 2013, "Navigating Time and Uncertainty in Health Technology Appraisal: Would a Map Help?," PharmacoEconomics, Springer, volume 31, issue 9, pages 731-737, September, DOI: 10.1007/s40273-013-0077-y.
  4. Christopher McCabe & Richard Edlin & David Meads & Chantelle Brown & Samer Kharroubi, 2013, "Constructing Indirect Utility Models: Some Observations on the Principles and Practice of Mapping to Obtain Health State Utilities," PharmacoEconomics, Springer, volume 31, issue 8, pages 635-641, August, DOI: 10.1007/s40273-013-0071-4.
  5. Ros Wade & Micah Rose & Aileen Neilson & Lisa Stirk & Rocio Rodriguez-Lopez & David Bowen & Dawn Craig & Nerys Woolacott, 2013, "Ruxolitinib for the Treatment of Myelofibrosis: A NICE Single Technology Appraisal," PharmacoEconomics, Springer, volume 31, issue 10, pages 841-852, October, DOI: 10.1007/s40273-013-0083-0.

2012

  1. Joachim Marti, 2012, "Assessing preferences for improved smoking cessation medications: a discrete choice experiment," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), volume 13, issue 5, pages 533-548, October, DOI: 10.1007/s10198-011-0333-z.
  2. Marti, Joachim, 2012, "A best–worst scaling survey of adolescents' level of concern for health and non-health consequences of smoking," Social Science & Medicine, Elsevier, volume 75, issue 1, pages 87-97, DOI: 10.1016/j.socscimed.2012.02.024.
  3. Musal, R. Muzaffer & Soyer, Refik & McCabe, Christopher & Kharroubi, Samer A., 2012, "Estimating the population utility function: A parametric Bayesian approach," European Journal of Operational Research, Elsevier, volume 218, issue 2, pages 538-547, DOI: 10.1016/j.ejor.2011.11.017.

2011

  1. Ge Yu & Adrian Renton & Martin Wall & Emee Estacio & Justine Cawley & Pratibha Datta, 2011, "Prevalence of Low Physical Activity and its Relation to Social Environment in Deprived Areas in the London Borough of Redbridge," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, volume 104, issue 2, pages 311-322, November, DOI: 10.1007/s11205-010-9745-x.

2007

  1. Stevens, Katherine & McCabe, Christopher & Brazier, John & Roberts, Jennifer, 2007, "Multi-attribute utility function or statistical inference models: A comparison of health state valuation models using the HUI2 health state classification system," Journal of Health Economics, Elsevier, volume 26, issue 5, pages 992-1002, September.
  2. John Brazier & Christopher McCabe, 2007, "‘Is there a case for using visual analogue scale valuations in CUA’ by Parkin and Devlin a response: ‘yes there is a case, but what does it add to ordinal data?’," Health Economics, John Wiley & Sons, Ltd., volume 16, issue 6, pages 645-647, June, DOI: 10.1002/hec.1246.
  3. Katherine Stevens & Christopher McCabe & John Brazier, 2007, "Response to Shmueli," Health Economics, John Wiley & Sons, Ltd., volume 16, issue 7, pages 759-761, July, DOI: 10.1002/hec.1228.

2006

  1. Katherine J. Stevens & Christopher J. McCabe & John E. Brazier, 2006, "Mapping between Visual Analogue Scale and Standard Gamble data; results from the UK Health Utilities Index 2 valuation survey," Health Economics, John Wiley & Sons, Ltd., volume 15, issue 5, pages 527-533, May, DOI: 10.1002/hec.1076.
  2. Mark J. Sculpher & Karl Claxton & Mike Drummond & Chris McCabe, 2006, "Whither trial‐based economic evaluation for health care decision making?," Health Economics, John Wiley & Sons, Ltd., volume 15, issue 7, pages 677-687, July, DOI: 10.1002/hec.1093.
  3. Karl Claxton & Mark Sculpher & Anthony Culyer & Chris McCabe & Andrew Briggs & Ron Akehurst & Martin Buxton & John Brazier, 2006, "Discounting and cost‐effectiveness in NICE – stepping back to sort out a confusion," Health Economics, John Wiley & Sons, Ltd., volume 15, issue 1, pages 1-4, January, DOI: 10.1002/hec.1081.
  4. McCabe, Christopher & Brazier, John & Gilks, Peter & Tsuchiya, Aki & Roberts, Jennifer & O'Hagan, Anthony & Stevens, Katherine, 2006, "Using rank data to estimate health state utility models," Journal of Health Economics, Elsevier, volume 25, issue 3, pages 418-431, May.
  5. Christopher McCabe & Katherine Stevens & Jennifer Roberts & John Brazier, 2006, "Erratum to ‘Health state values for the health utilities index mark 2 descriptive system: results from a UK valuation survey’ Health Economics 2005; 14(3): 231–244," Health Economics, John Wiley & Sons, Ltd., volume 15, issue 7, pages 761-761, July, DOI: 10.1002/hec.1136.

2005

  1. Christopher McCabe & Katherine Stevens & Jennifer Roberts & John Brazier, 2005, "Health state values for the HUI 2 descriptive system: results from a UK survey," Health Economics, John Wiley & Sons, Ltd., volume 14, issue 3, pages 231-244, March, DOI: 10.1002/hec.925.
  2. Karl Claxton & Mark Sculpher & Chris McCabe & Andrew Briggs & Ron Akehurst & Martin Buxton & John Brazier & Tony O'Hagan, 2005, "Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra," Health Economics, John Wiley & Sons, Ltd., volume 14, issue 4, pages 339-347, April, DOI: 10.1002/hec.985.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.